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Notch2, but not Notch1, plays indispensable roles in
kidney organogenesis, and Notch2 haploinsuffi-
ciency is associated with Alagille syndrome. We pro-
posed that proximal nephron fates are regulated by a
threshold that requires nearly all available free Notch
intracellular domains (NICDs) but could not identify
the mechanism that explains why Notch2 (N2) is
more important than Notch1 (N1). By generating
mice that swap their ICDs, we establish that the over-
all protein concentration, expression domain, or ICD
amino acid composition does not account for the
differential requirement of these receptors. Instead,
we find that the N2 extracellular domain (NECD) in-
creases Notch protein localization to the cell surface
during kidney development and is cleaved more
efficiently upon ligand binding. This context-specific
asymmetry in NICD release efficiency is further
enhanced by Fringe. Our results indicate that an
elevated N1 surface level could compensate for the
loss of N2 signal in specific cell contexts.
INTRODUCTION
The kidney is an essential organ with growing clinical importance
in the aging western population. It regulates excretion of soluble
waste, maintains pH and electrolyte balance, and controls blood
pressure and vitamin D levels. Its functional unit, the nephron,
consists of a filtration apparatus called the glomerulus, followed
by renal tubules made up of specialized epithelial cells that
modify the filtrate, which eventually flows into the collecting
duct system and drains into the bladder.
During development, nephrons form as the outcome of recip-
rocal interactions between the metanephric mesenchyme (MM)
and the ureteric bud (UB) (Costantini and Kopan, 2010).
Gonadal-derived neurotrophic factor (GDNF), secreted by theDevelMM, induces UB branching;Wnt9b, secreted by the UB, induces
a few MM cells to undergo mesenchymal to epithelial transition
(MET) and form a renal vesicle (RV), which grows into the
S-shaped body (SSB) after fusing with the ureteric stalk (Fig-
ure 1A; Georgas et al., 2009). Together with endothelial and
mesangial cells, the proximal third of the SSB forms the glomer-
ulus; the rest of the SSB gives rise to the various segments and
cell types that link the glomerulus to the collecting duct.
In both human and mouse, proper renal organogenesis re-
quires the Notch signaling pathway. This pathway is comprised
of four Notch receptors (N1–N4) and five canonical ligands
(Dll1, Dll3, Dll4, Jag1, and Jag2; Kopan and Ilagan, 2009). As
all receptors and ligands are type I transmembrane proteins,
the Notch pathwaymediates communications between adjacent
cells. Binding of the ligand to the Notch extracellular domain
(NECD) exposes the S2 cleavage site, which by default is
masked by the negative regulation region (NRR). Cleavage at
the S2 site is followed by intramembrane proteolysis at the S3
site by g-secretase, which releases the Notch intracellular
domain (NICD) from the cell membrane. Subsequently, NICD
translocates to the nucleus and forms a transcriptional activation
complex with RBP andMastermind on specific DNA sites to turn
on the expression of target genes, including Hes/Hey family
members. In addition to these core pathway components,
various other factors can modulate the strength of the Notch
signaling pathway (Kopan and Ilagan, 2009).
Despite the presence of N1, N2, Dll1, and Jag1 in the devel-
oping nephron, only haploinsufficiency in either JAG1 or N2
causes Alagille syndrome in humans, a disease characterized
by craniofacial abnormalities and heart, liver, and kidney malfor-
mations (Penton et al., 2012). McCright et al. (2002) showed that
in order tomodel Alagille syndrome inmice, simultaneous reduc-
tion of both N2 and Jag1 is required. Moreover, Cheng et al.
(2007) reported that whereas removal of N1 from the nephron
progenitors was well tolerated, conditionally removing N2 alone
from nephron progenitors in the intermediate mesoderm (with
Pax3-Cre) resulted in complete loss of the proximal nephron
and the death of newborn pups within 48 hr. In another study,
the contribution of N1 could only be revealed in a sensitizedopmental Cell 25, 585–598, June 24, 2013 ª2013 Elsevier Inc. 585
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et al., 2010). Thus far, a molecular explanation for the unequal
role of N2 (versus N1) and JAG1 (versus other ligands) in human
and mouse kidney development and disease has remained
elusive.
To address this question, we used multiple approaches to
determine whether differences in the spatial expression do-
mains, the expression level, or the amino acid composition could
account for the unequal contributions of N1 and N2 to nephron
development. We demonstrated that the expression levels of
N1 and N2 proteins are equivalent within the renal epithelia,
and that differential expression outside of this domain did not
contribute to the functional differences. To address the role of
amino acid composition, we seamlessly swapped the entire
N1ICD and N2ICD genomic coding regions to create two strains
of mice harboring genes we call N12 and N21. These mice pro-
vide a unique platform for distinguishing NICD dose-dependent
phenomena from NICD composition-dependent ones in various
tissues and disease models (Chu et al., 2011; Fan et al., 2004;
Graziani et al., 2008; Parr et al., 2004; Rangarajan et al., 2001).
Using these tools, we demonstrated that N1ICD and N2ICD
are fully interchangeable during kidney development: nephro-
genesis occurs normally in each of the 10,000 nephrons as
long as N2ECD controls ICD release, but fails to complete any
nephrons when N1ECD controls ICD release. This confirmed
the existence of a threshold, a developmental switch that is
controlled by the concentration, but not the composition, of
Notch ICDs. The switch determines whether an individual
nephron will develop its proximal elements (Cheng et al., 2007).
To gain more insight into how the ECD controls the free NICD
concentration, we determined whether N1ECD and N2ECD
differ in efficiency of ICD release in vitro using the Notch lucif-
erase complementation imaging (LCI) assay (Ilagan et al.,
2011). We show that when it is present at similar levels on the
surface of HEK293 cells, N2ECD is consistently, but onlymargin-
ally (2-fold), better than N1ECD at releasing ICD in response to
either Jag1 or Dll1. We further found that in RVs and SSB cells,
N2 is more abundant on the cell surface than N1. Using N12
and N21 strains, we demonstrated that this uneven distribution
is determined by the ECD. Finally, a series of ligand loss-of-func-
tion alleles revealed a dose-dependent effect for ligands and a
dominant requirement for Jag1 in the kidney context relative to
that of Dll1. This may be amplified by ECD glycosylation by
one of the three Fringe genes, Lunatic Fringe (Lfng), whose
expression overlaps with N1 in the developing nephron. We pro-
pose that the combined effects of these factors make the N2
contribution critical for kidney development. The importance of
the ECD in the kidney epithelial cell is also reflected in the label-
ing frequencies of N1::CreLO and N2::CreLO reporter mice (Liu
et al., 2011; Morimoto et al., 2010; Vooijs et al., 2007), in which
the release of Cre recombinase is solely determined by theNotch
ECD. In summary, these data imply that the number of NICD
molecules in the nucleus of RV cells is near the amount needed
to promote proximal nephron development, which would explain
why the loss of one N2 or Jag1 allele causes a developmental
syndrome in humans. Because the ICDs are interchangeable,
investigating N1 trafficking in organs affected by Alagille
syndrome may lead to therapeutic benefit without the risk asso-
ciated with agonist use.586 Developmental Cell 25, 585–598, June 24, 2013 ª2013 Elsevier IRESULTS
N1 and N2 Have Similar Expression Patterns in
Developing Renal Epithelia
We reasoned that the functional difference between the two
Notch paralogs during metanephric kidney development could
be explained by one mechanism or possibly a combination of
several mechanisms, including (1) differences in promoters/
enhancers, which give rise to differential temporal or spatial
expression domains by controlling messenger RNA (mRNA)
levels; (2) differences in the 30 UTRs, which may affect the
stability/translation of mRNAs of Notch paralogs and therefore
protein abundance; (3) differences in ECD composition, which
lead to differential responses to ligands and consequently
different numbers of NICD molecules released, resulting in
different signal ‘‘strengths’’; and (4) differences in ICD composi-
tion, which lead to differential associations with distinct binding
partners and activation of unique downstream targets (Spitz
and Furlong, 2012).
Up to now, a careful examination of the N1 and N2 expression
patterns in the developing kidney has not been possible due to
the lack of appropriate antibodies. After confirming the speci-
ficity of newly developed antibodies against the N1ICD and the
N2ICD (see below), we analyzed the expression patterns of these
receptors at embryonic day 17.5 (E17.5) using immunofluores-
cence on wild-type (WT) kidneys (Figure 1). Both receptors are
expressed in an overlapping cell population in the RV and SSB
that is thought to give rise to proximal tubules and podocytes
(Figures 1E–1L). In addition to the renal epithelia, N1 is ex-
pressed in endothelial precursor cells within the kidney anlagen
(Figure 1B, arrowheads). In contrast, N2 is broadly expressed in
the MM, vascular smooth muscle cells (VSMCs), and the UB, but
is absent from endothelial cells (Figures 1C and 1D).
The exclusive expression of N2 in theMMmay explain why this
protein is indispensable (Fujimura et al., 2010). However,
because progenitor maintenance and MET proceed normally in
the absence of N2 (Cheng et al., 2007; McCright et al., 2002),
N2 activation in MM is unlikely to perform a significant function
there (Boyle et al., 2011). To directly test whether N2 is activated
in MM cells, we examined the labeling pattern of an N2-
activation-dependent reporter line, N2::CreLO (Figure S1
available online; Liu et al., 2011; Vooijs et al., 2007). In this
reporter line, one copy of the N2ICD is replaced with Cre recom-
binase, which is released upon N2 activation. In the presence of
the reporter allele RosaCAG-EYFP (Madisen et al., 2010), the
released Cre will excise the floxed ‘‘stop’’ cassette between
the Rosa/CAG promoter and enhanced yellow fluorescent
protein (EYFP) reporter and activate EYFP expression,
indelibly marking cells that have experienced N2 activation
(and their progeny; Vooijs et al., 2007). The N2::CreLO labeling
pattern in E17.5 kidneys revealed only a few EYFP-positive cells
in Six2-positive MM cells (Figures 1M and 1O). The fewMM cells
that experience N2 activation will most likely exit the stem cell
niche (Boyle et al., 2011; Cheng et al., 2007; Fujimura et al.,
2010). If N2 receptors were activated in cells undergoing MET,
most RV cells would be labeled. Instead, only a few EYFP-
positive cells are detected in RVs. Consistent with Notch activa-
tion in the RV, many labeled cells are seen in the SSBs, proximal
tubules, and podocytes. N2 activation thus occurs in thenc.
Figure 1. Variation in the Expression Pattern of N1 and N2 Does Not Explain Their Functional Difference
(A) Diagram showing major structures of developing nephrons. The presumptive distal and proximal tubules, as well as podocyte precursor cells, are denoted in
purple, green, and red, respectively.
(B–L) Comparison of N1 and N2 expression in different structures of an E17.5 kidney. CD31 marks endothelial cells; smooth muscle actin (SMA) marks vascular
smooth muscle cells; cytokeratin 8 (CK8) marks UB and its derivatives; neural cell adhesion molecule (NCAM) marks all epithelial cells. Arrowheads denote
endothelial cell precursors.
(I–L) Double staining with N1ICD and N2ECD antibodies.
(M–O) Labeling pattern of N2::Cre reporter in E17.5 kidney. All scale bars are 10 mm except for (O), where it is 500 mm.
See also Figure S1.
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1M–1O). In summary, both receptors are expressed in the
domain where Notch proteins impact the decision to make
proximal nephron cells, and the differential expression of N2 in
the MM does not explain why N2 is essential for kidney develop-
ment but N1 is not.
ICD Swap between N1 and N2 Creates N12 and N21
Chimeric Receptors
All NICD paralogs form transcriptional activation complexes with
RBPjk and Mastermind on target promoters. Although Notch
proteins can activate similar targets and can act redundantly
in vivo (Riccio et al., 2008), in vitro and in vivo studies suggest
that in some contexts, these complexes are distinct because
NICD paralogs can have different or even opposite functions
(Chu et al., 2011; Fan et al., 2004; Graziani et al., 2008; Parr
et al., 2004; Rangarajan et al., 2001). Amino acids that are not
conserved between N1ICD and N2ICD are located at the
solvent-accessible surface of the Ankyrin domain and could
therefore participate in unique interactions with putative coacti-
vators or corepressors, contributing to their functional differ-
ences (Spitz and Furlong, 2012). To investigate this, we used
galK-selection-based bacterial artificial chromosomes (BAC)
recombineering (Warming et al., 2005) to swap the entire
genomic regions coding the ICDs between the N1 and N2 loci
in B6-derived embryonic stem cells (ESCs; Figure 2A; Figure S2).
The swapped region ranged from exon 28, coding for the trans-
membrane domain (TMD), to the stop codon in exon 34. In order
to retain transcript-specific regulation of mRNA stability and
translation, we did not swap the 30 UTRs. We designated the
alleles N12 (N2ICD in the N1 locus) and N21 (N1ICD in the N2
locus; Figure 2A). To facilitate ESC screening and postrecombi-
nation analysis with pyrosequencing-based methods (Liu et al.,
2009, 2010), we introduced silent single nucleotide variations
(SNVs) into the TMD coding regions (G38066C for N12 and
G125011C for N21), as well as an SNV in the ICD coding region
of N12 (G38129A; Figure 2A). After germline transmission was
obtained, the frt-flanked neomycin/G418 selection cassette
was removed by mating the mice with flippase deleter mice
(Rodrı´guez et al., 2000). This left a 34 bp frt sequence between
the stop codon and the 30 UTR in mice with N12 and N21 chro-
mosomes (Figure 2A; Figure S2).
PCR amplification confirmed the presence of the hybrid exon
28 in the genome (Figures S3A and S3B). Loss of sequences
from N1 exon 30 or N2 exon 34, respectively, identified N112/12
and N221/21 homozygous mice, which are both viable (Figures
S3A and S3B; a detailed phenotypic analysis of other organs
will be described elsewhere). The loss of N1ICD in N112/12 or
N2ICD in N221/21 mice was also confirmed by western blot with
N1ICD- and N2ICD-specific antibodies, respectively (Figure 2B).
The introduced SNVs allowed us to compare the mRNA levels
transcribed from the N12 chromosome to N1 and the N21 chro-
mosome to N2 in various heterozygous tissues of N1+/12 and
N2+/21 mice, respectively, with pyrosequencing (Figure 2C).
This analysis revealed that the shorter transcript was slightly
more abundant in all tissues examined (Figure 2C). Western
blot and immunostaining with either anti-Notch ICD or anti-
Notch ECD antibody confirmed the expression of chimeric pro-
teins (Figure 2B; Figures S3C and S3D). To assess whether the588 Developmental Cell 25, 585–598, June 24, 2013 ª2013 Elsevier Ichimeric Notch receptors could reach the cell surface as effi-
ciently as the endogenous receptors, we isolated RV and SSB
cells from Lfng-GFP mice, in which EGFP is expressed under
the control of LFng regulatory sequences. Double staining of
E17.5 kidneys with either N1ICD or N2ICD antibodies showed
an extensive overlap with EGFP (Figures 2D–2G; Figure S3E).
To exclude the epithelial cells from differentiated tubules, we
isolated GFP+ cells from E13.5, Lfng-GFP; N1+/+; N2+/+ (denoted
as WT), Lfng-GFP; N112/12; N2+/+ (denoted as N112/12) and Lfng-
GFP; N1+/+; N221/21 (denoted as N221/21) kidneys before tubule
formation (Figure 3H), and stained them with anti-N1ECD- or
anti-N2ECD-specific antibodies (Fiorini et al., 2009). Flow
cytometry analysis confirmed that the cell-surface distribution
of N12 and N21 was similar to that of N1 and N2, respectively
(Figure 3I).
N1ICD and N2ICD Are Interchangeable in the Kidney
We previously showed that conditional deletion of N2 from the
intermediate mesoderm (with Pax3-Cre) produced mice with
nonfunctional, hypoplastic kidneys lacking podocytes and
proximal tubules (Cheng et al., 2007). We found that N221/21
and compound heterozygous N1+/; N221/ mice (both lacking
N2ICD) formed functional nephrons in normal numbers (Figure 3).
This result demonstrates that even a single copy of N1ICD can
fully rescue the loss of N2ICD when expressed from the N2
locus. In contrast, when the endogenous N2 alleles are condi-
tionally deleted, even the presence of two copies of N2ICD ex-
pressed from the N1 locus (Pax3-Cre; N2f/f; N112/12) cannot
rescue a single nephron (Figure 3). These mice were indistin-
guishable from Pax3-Cre; N2f/f mice in terms of kidney
morphology and died within 24 hr of birth (Figure 3). These
data demonstrate that N1ICD and N2ICD are fully interchange-
able, and that the functional differences between N2 and N1
are determined by differences in their ECDs and/or their corre-
sponding protein levels during kidney development.
N2 and N1 Promoters/30 UTRs Deliver Similar Levels
of Protein in RV and SSB Cells
We next sought to determine whether N1 is less abundant than
N2 protein within RVs and/or SSBs, which would explain the
differences in their function during kidney development. This is
a technically challenging question to answer, for two reasons:
first, it proved impractical to isolate enough RV and SSB cells
for western blot analysis; second, different antibodies that
recognize unique epitopes in Notch paralogs may have different
affinities, making the comparison difficult. Fortunately, the
domain swap gave us the opportunity to examine N2ICD protein
levels by immunostaining in WT (where N2ICD production is
under the control of the endogenous N2 locus) and N12; N21
double-homozygous (N112/12; N221/21) mice (where all N2ICD
production is under the control of the N1 locus).
To perform this experiment, we first confirmed the specificity
of the anti-N1ICD and anti-N2ICD antibodies on kidney sections
from either N112/12 or N221/21 mice (Figures 4A and 4B). Next, we
used the anti-N2ICD antibody and analyzed immunostained
kidneys from N2+/, WT, and N112/12; N2+/+ mice, which have
one, two, and four copies of the N2ICD antigen, respectively
(Figures S4A–S4C). Pixel intensity correlated well with gene
dose (Figure S4D), confirming that this assay is sensitive enoughnc.
Figure 2. Generation of the N12 and N21 Alleles
(A) Schematic illustration of N1 (blue) and N2 (red) loci before and after the ICD swap. The N1ICD encompasses 5,926 bp on chromosome 2, ranging from
nucleotide +38,103 to +44,028 (A in ATG is +1) and encoding amino acid 1,750 to 2,531; for N2, the ICD encompasses 8,699 bp on chromosome 3, ranging from
nucleotide +125,048 to +133,746 and encoding amino acid 1,705 to 2,473. Amino acids in black denote the S3 cleavage sites. Green triangle denotes FRT site.
(B) Western blot analyses with ICD-specific antibodies of kidney extracts from newborn pups with designated genotypes (WT, N112/12, and N221/21; two different
individuals per genotype).
(C) mRNA level comparisons between chimeric N12 and N21 and their corresponding endogenous alleles in various tissues of WT, N1+/12, and N2+/21 newborn
pups. Allele ratios were calculated by determining the G/C ratio at SNVs G38066C and G125011C introduced into the targeting constructs with pyrosequencing.
Error bars represent SD.
(D–G) Double staining of EGFP and N1 (D and E) or N2 (F and G) on E17.5 Lfng-GFP kidneys. Asterisks (*) denote EGFP+ tubules.
(H) EGFP labeling patterns in E13.5 Lfng-GFP kidney.
(I) E13.5 Lfng-GFP kidneys with WT or single homozygous (N112/12 or N221/21) Notch alleles were dissociated into single cells, stained with PE-conjugated
N1ECD- or N2ECD-specific antibodies (eBioscience), and analyzed by flow cytometry. The cell-surface levels of WT (N1, N2) and chimeric (N12, N21) receptors
were compared in EGFP+ cells. Scale bars: (D–G) 10 mm; (H) 100 mm.
See also Figures S2 and S3.
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Figure 3. Notch ICDs Can Functionally Replace Each Other in Kidney Development
Kidney phenotypes were characterized in newborn mice with the indicated genotypes. Scale bars: 500 mm for whole kidneys, and 20 mm for the magnified
windows showing WT1 and LTL staining. SDs of nephron number are shown in parentheses.
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N221/21 mice. Finally, we compared the abundance of N2ICD
protein levels in kidneys from WT and N112/12; N221/21 by immu-
nostaining (Figure 4). Anti-N2ICD antibody staining of N112/12;
N221/21 kidneys confirmed that N2ICD recapitulated the N1
expression pattern, including its strong expression in the devel-
oping RVs, SSBs, and all endothelial precursor cells, and its
absence from the MM (Figures 4C and 4D). Importantly, the
expression levels in RVs and SSBs were comparable in the590 Developmental Cell 25, 585–598, June 24, 2013 ª2013 Elsevier Itwo samples (Figures 4E and 4F). Therefore, the functional differ-
ences between N1 and N2 could not be attributed to differential
expression levels, microRNA targeting of their 30 UTRs, or their
ICD composition.
Receptors Containing N2ECDAreMore Abundant on the
Plasma Membrane of RV and SSB Cells
Since only receptors on the cell surface could engage with
ligands for activation, we sought to determine whether thenc.
Figure 4. Comparison of the Total and Surface Levels of N1 and N2 in Developing Nephron Epithelia
(A and B) Confirmation of the specificity of anti-N1ICD and -N2ICD antibodies on kidney sections from N112/12 (A) and N221/21 (B) mice.
(C and D) Anti-N2ICD antibody staining on kidney sections from N112/12; N221/21 double-homozygous mice, in which all N2ICD is expressed from the N1 locus.
(E and F) The levels of protein expressed from the N1 andN2 loci in developing RVs and SSBswere compared by immunostaining with N2ICD-specific antibodies
on N112/12; N221/21 mice (the N1 locus; E) and WT (the N2 locus; F). The secondary antibody was used without signal amplification and exposure times were
identical for the red channel to allow quantitative comparisons. Arrowhead denotes endothelial cells.
(G) Flow cytometry analysis on EGFP+ live cells from E13.5 Lfng-GFP kidneys with two different sets of anti-Notch ECD antibodies. All scale bars: 10 mm.
See also Figure S4.
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etry, using LFng-GFP kidneys (Figure 2H). Tominimize antibody-
based artifacts, we employed two different sets of monoclonal
anti-N1ECD and anti-N2ECD antibodies: one raised in Armenian
hamster (Moriyama et al., 2008) and one raised in rat (Fiorini
et al., 2009). The geometric mean fluorescence intensity
(GMFI) of antibodies against N2 in EGFP+ epithelial cells isolated
from E13.5 Lfng-GFP kidneys is 4-fold (4.5 ± 1.0) higher than
that generated by anti-N1 antibodies (Figure 4G). To ensure
that this result did not reflect differential affinity, we sorted stable
HEK293 cell lines in which surface biotinylation assays
confirmed that the amounts of N1ECD and N2ECD on the cell
surface were similar (described in the next section and in Figures
S5A–S5C). The results show that the differences in affinity
between N1 and N2 antibodies (Figure S5D) could account for
only a fraction of the distribution difference seen in the RVs
and SSBs. Therefore, N2 is more abundant than N1 on the
surface of renal epithelial cells in the developing nephron. Most
importantly, because N21 has the same surface abundance as
N2 (Figure 2I), the ECD, but not the ICD, determines the surface
level of N2 and N1.
N2ECD Releases More N1ICD than N1ECD Does in
Response to Ligands
Considering that only one allele of N2 is sufficient for normal
kidney development, but two alleles of N1 are not (Figure 3), a
small difference in surface distribution alone may not explain
the functional dominance of N2. Therefore, we asked whether
differences in ECD composition could also impact the amountDevelof ICDs released in response to ligand. To address this, we
used a quantitative in vitro assay based on the LCI system in
kidney-derived HEK293 cells (Figure 5A; Ilagan et al., 2011).
We first fused the carboxy-terminal half of luciferase (CLuc) to
the N terminus of RBP and generated two parental CLuc-RBP-
expressing HEK293 Flp-In cell lines by random integration.
Then we fused the N-terminal half of luciferase (NLuc) to the C
terminus of full-length N1 and N21, respectively, and targeted
them into the same genomic locus in the two parental cell lines
using the Flp-In system (Figure 5A). In these Notch Flp-In cells,
the isogenic expression of N1-NLuc and N21-NLuc minimizes
positional effects and ensures similar expression levels (Figures
S5A–S5C). In the absence of ligand binding, N1-NLuc and N21-
NLuc fusion proteins are anchored to the cell membrane,
whereas CLuc-RBP fusion protein is segregated into the nucleus
and no luciferase activity is detected. The binding of ligands to
the ECD (or unfolding of the NRR by calcium chelation with
EGTA) triggers receptor proteolysis and the release of the
N1ICD-NLuc fragment, which then translocates into the nucleus
and interacts with CLuc-RBP to reconstitute a quantifiable lucif-
erase activity. The amount of light emitted is directly proportional
to the amount of N1ICD released and is therefore a measure of
signal strength (Ilagan et al., 2011). To control for cell-line
specific variations, we tested a total of ten N1-NLuc subclones
and ten N21-NLuc subclones for each of the two CLuc-RBP
parental cell lines.
To compare the signal strengths of N1 and N21 in these cells,
we cocultured the Notch Flp-In cells with either ligand-present-
ing cells (Chinese hamster ovary [CHO]-Dll1 or CHO-Jag1) oropmental Cell 25, 585–598, June 24, 2013 ª2013 Elsevier Inc. 591
Figure 5. N2ECD Is More Potent than
N1ECD in Mediating Ligand-Induced ICD
Release
(A) The Notch LCI strategy for comparing the
potency of N1ECD and N2ECD: NLuc is fused to
the C terminus of N1 or N21. These two constructs
were expressed from the same genomic locus in
parental cell lines that stably express CLuc-RBP.
For both N1 and N21, activation releases N1ICD-
NLuc. The subsequent interaction of N1ICD-NLuc
with CLuc-RBP reconstitutes luciferase. The
amount of NICD released is proportional to the
light produced.
(B and D) LCI results for ten independent cell lines
in the presence of either (B) cocultured ligand-
expressing cells (CHO-Dll1 and CHO-Jag1) or (D)
100 mM EGTA (*p < 106, Student’s t test).
(C) The stability of N1ICD-Nluc fragments released
from N1 and N21 fusion proteins, which differ by
six amino acids at the N terminus (VLLSRK and
VIMAKR, respectively), was determined by the
luminescence lifetime measurements after block-
ing NICD-NLuc release with the g-secretase
inhibitor DAPT. Thick lines in (C) and (D) represent
the average of N1 and N21 cell lines. All scale bars
represent SD.
See also Figure S5.
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light was emitted from N21-NLuc than from N1-NLuc cells (p <
106, Student’s t test; Figure 5B; similar results were obtained
with subclones derived from the other CLuc-RBP-expressing
parental cell line [not shown]). Considering that the released
N1ICD-NLuc fragments from N21-NLuc and N1-NLuc differ by
six amino acids at their N-termini (VLLSRK for N1-NLuc versus
VIMAKR for N21-NLuc), we tested whether differential stability
could account for the apparent difference in bioluminescence
between N1-Nluc and N21-NLuc. After activating the reporter
cells overnight on immobilized ligand, we added a g-secretase
inhibitor (DAPT) to block the release of additional N1ICD-NLuc
fragments and followed the decay of bioluminescence as a func-
tion of time (Figure 5C). The N1ICD-NLucVLLSRK proved to be as
stable as the N1ICD-NLucVIMAKR, allaying the concern that we
were detecting differences in protein stability. Finally, as
mentioned above, the amounts of N1 and N21 on the cell surface
were similar (Figure S5), suggesting that the difference in lumi-
nescence is not simply due to unequal amounts of surface
receptors. Collectively, these experiments suggest that N2ECD
is more efficient in eliciting ligand-mediated receptor activation
in kidney cells.
The activation of Notch receptors requires the unfolding of the
NRR domain within the ECD to expose the S2 cleavage site
(Kopan and Ilagan, 2009). We therefore tested whether differ-
ences in the dynamics of NRR unfolding might contribute to
the differences between the two ECDs. We monitored the
kinetics of N1 and N21 activation in our Flp-In lines in the pres-
ence of the calcium chelator EGTA for 1 hr. After 30 min of
EGTA treatment, more bioluminescence was detected with
N21-NLuc than with N1-NLuc (Figure 5D), suggesting that subtle592 Developmental Cell 25, 585–598, June 24, 2013 ª2013 Elsevier Idifferences in NRR unfoldingmay contribute to the higher activa-
tion probability of N21.
Dll1 and Jag1 Contribute Differentially to Nephron
Segmentation
Two major Notch ligands, Dll1 and Jag1, are expressed in the
developing renal epithelia (Chen and Al-Awqati, 2005; Leimeis-
ter et al., 2003). Coimmunostaining of SSBs shows that their
expression domains largely overlap with each other (Figure 6A),
with LFng (Figures 2E and 2G; Figure S3E), and with Notch re-
ceptors in the middle part of the SSBs (Figures 6B–6D). To
assess the contribution of each ligand to nephron development,
we created an allelic series of conditionally deleted ligands in
the MM using Six2-Cretg/+ (Kobayashi et al., 2008; Figures
6E–6P). Because Six2-Cre is strongly expressed in MM cells
from which all renal epithelial cells are derived, near-complete
deletion of floxed Jag1 and Dll1 is achieved at the genomic
DNA level in these cells (Figures S6A–S6D). Staining with the
proximal tubule marker LTL revealed mildly disrupted nephron
development in Dll1 mutants (Figure 6H) but a drastic reduction
in the number of nephrons in Jag1 mutants (Figure 6J). Interest-
ingly, in the presence of one Jag1 allele (Six2-Cretg/+; Dll1f/f;
Jag1+/f), nephron number was severely compromised, but
some WT1+ podocytes formed (compare Figures 6N and 6M);
the presence of one Dll1 allele could not support production
of podocytes, despite the presence of some proximal tubules
(Figure 6O). Simultaneous deletion of both ligands led to a
near-complete loss of nephrons (Figures 6L and 6P), approach-
ing the drastic phenotype seen in N2 mutants in which both
glomeruli and proximal tubules are missing (Cheng et al.,
2007). These data collectively demonstrate that although bothnc.
Figure 6. Jag1 Is the Dominant Ligand of N2 in the Kidney
(A–D) Comparison of N1, N2, Dll1, and Jag1 expression in the developing nephron.
(E–P) Phenotypes of newborn kidneys after ligand deletion. Scale bars: (A–D and M–P) 10 mm; (E–L) 500 mm.
See also Figure S6.
Developmental Cell
Notch2 ECD Determines Its Dominant Role in Kidney
Developmental Cell 25, 585–598, June 24, 2013 ª2013 Elsevier Inc. 593
Figure 7. Modulation by Lfng Contributes
to the Dominance of N2 in the Developing
Kidney
(A–C) In situ hybridization of three fringe genes in
the developing kidney. Inset in (A) shows an RV.
(D) Effects of Lfng modification on Notch1 and
Notch21 activation in HEK293 cells (*p < 0.05,
Student’s t test). All scale bars represent SD.
(E–H) Comparison of the labeling pattern between
N2::CreLO (E) and N1::CreLO (F–H) in vivo in
developing nephrons. Arrowheads denote endo-
thelial cells.
(I) A model proposing an NICD-dependent switch
that regulates proximal nephron development and
explaining how N2 achieves its dominant roles
over N1. See Discussion for details. The weight of
lines indicates the weight of effects. Scale bars:
(A–C, G, and H) 10 mm; (E and F) 500 mm.
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Jag1 plays a dominant role in general and in the development
of podocytes in particular.
Fringe family members can modulate the response of N1 and
N2 toDll1 and Jag1 ligands. Inmost contexts, fringemodification
renders N1more responsive to Dll1 ligand and less responsive to
Jag1. In contrast, fringe modification of N2 can potentiate,
reduce, or have no effect on ligand-mediated signaling, depend-
ing on the context (Stanley and Okajima, 2010). We therefore
examined the expression pattern of the three fringe family mem-
bers by in situ hybridization in E17.5 kidneys (Figures 7A–7C).We
detected only Lfng, which was expressed in a pattern similar to594 Developmental Cell 25, 585–598, June 24, 2013 ª2013 Elsevier Inc.that of EGFP from Lfng-GFP mice, with
strong signal in some epithelial cells of
RVs and the middle segment of SSBs,
and weak signal in differentiated tubules
(Figure 7A). We next compared the rela-
tive amounts of NICD released from N1-
NLuc and N21-NLuc cell lines cocultured
with Dll1- or Jag1-expressing CHO cells
in the presence and absence of LFng.
Overexpression of Lfng significantly
enhanced the N1-NLuc response to Dll1
and suppressed its response to Jag1. In
contrast, its effects on N21-NLuc were
minimal (Figure 7D; only three lines of 20
are shown). Although the net loss in
response to Jag1 may be offset by the
gain in response to Dll1 in vitro (Fig-
ure 7D), these data suggest that fringe
could contribute to the unequal contribu-
tion of N1 and N2 in vivo.
N2ECD Released Cre More
Efficiently than N1ECD in
Developing Nephrons of N::Cre
mice
All of the data presented thus far ascribe
the difference between N1 and N2 to
their ECDs. Unfortunately, we have notyet identified antibodies that specifically recognize activated
N2ICD. Therefore, we used a surrogate assay to compare N1
and N2 cleavage in vivo by comparing the effectiveness of
Cre release in two activation-dependent Notch reporter mice:
N1::CreLo (Liu et al., 2011; Vooijs et al., 2007) andN2::CreLo (Fig-
ure S1). The release of Cre in both lines is under the control of a
Notch ECD, and Cre activity will provide an estimate of the effi-
ciency of its release. Many labeled epithelial cells were seen in
RVs and SSBs of N2::CreLo; RosaCAG-EYFP mice (Figures 1M–
1O and 7E). In contrast, we could not find any labeled epithelial
cells in RVs or SSBs of N1::CreLo; RosaCAG-EYFP mice, although
endothelial cells are very efficiently labeled (Figures 7F–7H), as
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obtained immunohistological and genetic evidence that N1ICD
complements N2 activity in a sensitized background (Cheng
et al., 2007; Surendran et al., 2010), these observations are
consistent with amodel in which renal epithelia N2 is more abun-
dant at the cell surface, where it undergoes proteolysis more effi-
ciently than N1 in response to available ligands. Similar to the
case with Notch ICDs, only Cre6MT released by N2ECD, but
not N1ECD, reached the concentration threshold needed to
excise the floxed stop allele in renal epithelial cells.
DISCUSSION
Results from human patients and mouse models of Alagille syn-
drome support the idea that kidney development is particularly
sensitive to N2 dosage even in the presence of N1. We investi-
gated several possible mechanisms that could explain the domi-
nant contribution of N2 over N1 to nephrogenesis (Cheng et al.,
2007; Surendran et al., 2010). A precise mechanistic under-
standing not only would enhance our knowledge of how Notch
signaling contributes to kidney organogenesis but, more impor-
tantly, could also provide insights into therapeutic options for the
kidney defects seen in Alagille syndrome (Penton et al., 2012)
and perhaps other Notch-related congenital disorders. Further-
more, such an understanding could prove generally applicable
to many other organs and signaling pathways.
Although N2 is expressed in the MM, none of the known Notch
ligands or targets are expressed there (Boyle et al., 2011; Chen
and Al-Awqati, 2005; Leimeister et al., 2003; Ong et al., 2006).
Consistent with a ligand-poor environment, N2 activation is an
infrequent event in the MM. Genetic analyses confirmed that
Notch proteins function in nascent renal epithelial cells (this
study; Cheng et al., 2007; Wang et al., 2003), where the N1
and N2 expression domains are indistinguishable (Chen and
Al-Awqati, 2005; Leimeister et al., 2003). These results rule out
enhancer evolution as the mechanistic explanation for the func-
tional importance of N2.
We therefore focused on two alternative hypotheses: either
N1ICD is a weak activator of key target(s) that are normally
regulated by N2ICD due to its amino acid composition, or
N1ICD concentration is insufficient to functionally compensate
for N2 deficiency. To differentiate between these possibilities,
we generated two alleles of Notch (N12 and N21) in which we
swapped the entire genomic sequences coding for Notch
ICDs, in contrast to a previous study that established the equiv-
alence of the domain C-terminal to the ankyrin repeats of Notch
(Kraman and McCright, 2005). The availability of mice in which
the same epitope is transcribed and translated from different
loci enabled comparison of protein abundance with the same
ICD-specific antibody. This analysis demonstrated that the two
paralogs are expressed at similar levels in the developing renal
epithelium, and therefore differences in overall protein concen-
tration cannot explain the dominant role of N2.
We next addressed the role of Notch amino acid composition.
We demonstrated that N1ICD and N2ICD are fully interchange-
able during kidney development—even one copy of N1ICD ex-
pressed under the control of N2ECD is sufficient to produce a
normal kidney. If neither the overall protein concentration nor
the NICD composition can explain the unequal roles of N1 andDevelN2 in the developing kidney, ECD control over NICD nuclear con-
centration is likely the differentiating factor between N2 and N1.
We discovered that N2ECD indeed generates more NICD than
N1ECD does in the renal epithelial cell context, by a combination
of twomechanisms. First, N2 ismore abundant at the cell surface
than N1. Accounting for the differences in affinity between anti-
N1 and anti-N2 antibodies, the difference is between 2- and
3-fold. Importantly, N21 and N2 are equally abundant at the cell
surface, indicating that surface distribution is determined by
sequences in the Notch ECD, not the ICD. Although other trans-
membrane proteins may contain trafficking signals in their ECD
(Albu and Constantinescu, 2011; Steiner et al., 2008; Vanden-
Bussche et al., 2009), the only indication that the Notch2 ECD
may play a role in its trafficking comes from a study on the impor-
tance of S1 cleavage to the exocytosis of N1, but not N2 (Gordon
et al., 2009). Second, in LCI assays (Ilagan et al., 2011) that quan-
tified the amount of NICD released from N21 and N1 in cultured
human embryonic kidney cells in response to ligand or EGTA,
N21 consistently released more N1ICD. In the EGTA paradigm,
all surface receptors are activated. Given that surface bio-
tinylation confirmed that N1 and N21 are present at equal
amounts, and the NICDs have the same half-life, we conclude
that theN2NRRmust be easier to activate thanN1NRR in kidney
epithelia, and since it contains the S1 site, it may regulate exocy-
tosis as well. However, where the trafficking signals reside within
theECD, andwhether theyonly function in thedeveloping kidney,
remains to be investigated. Supporting the conclusion that the
ICD passively reflects the advantages provided by a specific
ECD, N2ECD is more potent than N1ECD in Notch::Cre reporter
mice, where the amount of Cre that is released directly reflects
the activation frequency by the respective Notch ECD.
These two factors (surface density and ease of activation) may
work in synergy or simply be additive, but other factors may
serve to further amplify the effectiveness of N2ECD in vivo. As
reported before (Hicks et al., 2000), the response of N1 to Jag1
is significantly inhibited by Lfng modification, whereas that of
N2 is not. Considering that Lfng is coexpressed with N1 and
N2 in the epithelial cells of developing nephrons, it may be pro-
moting a potent N2-JAG1 signaling axis during nephrogenesis.
Indeed, analysis of ligand loss-of-function alleles showed that,
although Dll1 and Jag1 are coexpressed with N1 and N2, Jag1
plays a dominant role. This is consistent with reports that only
mutations in JAG1, and not in DLL1, cause Alagille syndrome
(Piccoli and Spinner, 2001).
The data presented here indicate that an NICD nuclear con-
centration threshold must be met to define the identity of the
proximal renal epithelia, and this threshold acts as a digital
(all-or-nothing) switch (Figure 7I). This is very reminiscent of the
intestinal differentiation program in Caenorhabditis elegans (Raj
et al., 2010). In that system, mRNA levels must rise above a
threshold to activate expression of a master regulatory gene.
The relative strength, or penetrance, of various alleles reflects
the number of cells that reach the ON decision. In the Notch sys-
tem, variability in the number of NICDs released to the nucleus
may regulate an ON/OFF decision to form the proximal nephron.
The advantage of N2ECD/NRR and the large impact of these dif-
ferences suggest that the overall numbers of NICD in the nucleus
are just above the ON state in RV cells and thus are highly prone
to perturbations. Whether a master regulator lies downstream ofopmental Cell 25, 585–598, June 24, 2013 ª2013 Elsevier Inc. 595
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to promote proximal development remain unknown.
In summary, our experiments have provided strong evidence
for a functional equivalence between N1ICD and N2ICD in vivo,
despite apparent differences in multiple assays based on over-
expression, including our own (Ong et al., 2006). A higher surface
level coupled with greater responsiveness of N2ECD to ligand
translates into a higher probability of NICD release during a
critical step in kidney development. These data illustrate the
binary nature of a critical step in nephron segmentation, where
nephrons with an NICD concentration below a certain threshold
fail completely to produce proximal structures, and highlight an
underappreciated importance for the ECD/NRR in controlling
surface distribution. In contrast to binary response to NICD
levels, the outcome of ligand reduction is graded: nephrons
can form proximal tubules without podocytes when only Dll1 is
present, suggestive of a second Notch-dependent decision.
Finally, investigation into Notch paralogs trafficking to the cell
surface may provide leads for treating the renal (and perhaps
all) manifestations of Alagille syndrome.
EXPERIMENTAL PROCEDURES
Mice
Generation, genotyping strategy, and PCR primers related to N12 and N21
mice and the source of other mouse lines are described in detail in Supple-
mental Experimental Procedures. All mice were housed in the Washington
University animal facility, and all experimental procedures were approved by
the Washington University Animal Studies Committee.
Pyrosequencing
Total RNA was purified, reverse transcribed, and used for pyrosequencing as
described previously (Liu et al., 2010).
Immunohistochemistry
Kidneys were dissected and fixed in 4% paraformaldehyde overnight, washed
extensively with 13 PBS, soaked overnight in 30% sucrose, and embedded in
optimal cutting temperature medium for frozen sections, or dehydrated
through a 30%, 50%, 70% ethanol series and embedded for paraffin sections.
For frozen sections, antigen retrieval was achieved by permeabilization in 13
PBS, 0.1% Triton X-100 for 20 min at room temperature. For paraffin sections,
this was achieved by boiling in 10 mM sodium citrate (pH 6.0) for 20 min. For
both frozen and paraffin sections, 13 PBS containing 3% BSA and 0.1%
Tween was used for blocking. Detailed information on the primary antibodies
and their dilution is provided in Supplemental Experimental Procedures. FITC-,
Cy3-, and Cy5-conjugated secondary antibodies or streptavidin (Jackson
ImmunoResearch) were used for visualization.
Flow Cytometry
Flow cytometry was performed as described previously (Liu et al., 2011).
Briefly, E13.5 embryonic kidneys were dissected, mechanically disrupted,
and digested with 1 mg/ml collagenase at 37C for 15 min to obtain single-
cell suspensions. Cells were further washed and stained with PE- or APC-
conjugated anti-N1ECD or -N2ECD antibodies (eBioscience and Biolegend)
in staining buffer (13 PBS +3% BSA) on ice for 20–30 min, followed by flow
cytometry analysis. Cultured 293 cells were mechanically removed from
culture plates and analyzed in a similar manner. Data were collected on a
BD FACScan with FlowJo Collectors’ Edition and analyzed with FlowJo
software (TreeStar).
In Situ Hybridization, Western Blot, and Nephron Number
Quantification
Conventional methods were used for in situ hybridization. Probes for lunatic,
radical, and manic fringe were labeled with digoxigenin and detected with596 Developmental Cell 25, 585–598, June 24, 2013 ª2013 Elsevier Ialkaline phosphatase-conjugated anti-digoxigenin antibody (Roche). Kidneys
from newborn pups or cultured cells were used for western blotting. The num-
ber of nephrons was determined as previously described (Godley et al., 1996).
Details are described in Supplemental Experimental Procedures.
Generation and Maintenance of Isogenic N1 and N21 LCI Reporter
Lines
Flp-InTRex293 host cells (R780-07; Invitrogen), which were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), 2 mM L-glutamine, 1% Pen-Strep (henceforth referred
to as media), and 100 mg/ml Zeocin, were cotransfected with pcDNA3-(Click
beetle green) CBG CLuc-RBP and a Puromycin expression construct using
FuGENE6 (Roche). Puromycin-resistant clones were selected in media con-
taining 0.6 mg/ml puromycin to generate Flp-InTRex 293 CBG CLuc-RBP
parental cell lines. We performed LCI on CBG CLuc-RBP-expressing clones
by transiently transfecting a constitutively active N1DE-NLuc plasmid to
verify luciferase complementation. Two LCI-positive clones, D10 and D6,
were selected as the CLuc-RBP parental cell lines and expanded in media
containing 0.4 mg/ml puromycin and 100 mg/ml Zeocin. Stable expression of
CLuc-RBP after different passages was confirmed by western blot. To
generate N1-NLuc and N21-NLuc Flp-In cells, D10 and D6 clones were
cotransfected with pcDNA5/FRT expression vector (V6010-20; Invitrogen)
containing either N1-CBG NLuc or N21-CBG NLuc and pOG44 vector at a
1:9 ratio. Positive clones, identified by selection for hygromycin resistance
(150 mg/ml) and gain of Zeocin sensitivity, were tested for their ability
to reconstitute luciferase activity upon EGTA treatment. Subsequently,
20 subclones were maintained in media containing 0.4 mg/ml puromycin
(to maintain CBG CLuc-RBP) and 100 mg/ml hygromycin (to maintain Notch
CBG NLuc).
LCI Assays
LCI assays are described in detail in Ilagan et al. (2011). For ligand-dependent
activation, 104 ligand-presenting cells (CHO-Dll, CHO-Jag, or CHO control
cells) were seeded into each well of uncoated, 96-well black plates 24 hr prior
to the seeding of 4 3 104 N1-NLuc or N21-NLuc cells. After another 24 hr,
cocultured cells were imaged in phenol red-free culture medium containing
150 mg/ml D-luciferin. For the ligand-independent activation assays, 96-well
black plates were coated with 0.1 mg/ml poly-lysine at room temperature
overnight, washed twice with PBS, and air-dried for 30min before 43 104 cells
were seeded into each well. Twenty-four hours later, an initial image (t = 0) was
obtained of the cells using Hank’s balanced salt solution (HBSS) containing
150 mg/ml D-luciferin (100 ml/well). Then, another 100 ml of HBSS/D-luciferin
solution containing 23 EGTA (200 mM) was added per well and images were
obtained every 5 min for 1 hr.
To monitor the rate of NICD degradation, 96-well black plates were coated
with 5 mg/ml anti-Fc antibody (Jackson ImmunoResearch) for 6 hr at 4C.
Unbound antibodies were washed off twice with PBS, and conditioned
media containing Fc control or Dll1-Fc/Jag-Fc were added (50 ml/well) and
incubated overnight at 4C. Excess ligands were washed off twice with
PBS before cells were seeded. Reporter cells were plated on the immobilized
ligands as described previously (Ilagan et al., 2011). After 24 hr, an initial
image was obtained (t = 0), after which DMSO or DAPT (5 mM) was added
to the wells to stop NICD production, and images were taken every hour
for 6 hr. Additional, detailed methods for ligand-conditioned media prepara-
tion, IVIS imaging, and photon flux quantification can be found in Ilagan et al.
(2011).
Surface Biotinylation Assay
Surface biotinylation was used to compare the surface levels of N1-NLuc and
N21-NLuc in Flp-In cells. Details are described in Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.devcel.2013.05.022.nc.
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